Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Rheumatology|March 2, 2023
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre studyEdoardo Conticini, Miriana d'Alessandro, Silvia Grazzini, et al.
Arthritis Research & Therapy|June 16, 2019
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profilesJohn A Reynolds, Tracy A Briggs, Gillian I Rice, et al.
Rheumatology (Oxford, England)|October 17, 2022
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational studyNadège Cordel, Benoît Dechelotte, Fabienne Jouen, et al.
Seminars in Arthritis and Rheumatism|January 19, 2024
Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal studyKarin Lodin, Fabricio Espinosa-Ortega, Maryam Dastmalchi, et al.
Frontiers in Genetics|August 19, 2021
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MuscleOlivier Boyer, Gillian Butler-Browne, Hector Chinoy, et al.
The Lancet. Rheumatology|March 16, 2023
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trialAndrew L Mammen, Anthony A Amato, Mazen M Dimachkie, et al.
Clinical Pharmacology and Therapeutics|June 21, 2019
Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research DatalinkDaniel F Carr, Ben Francis, Andrea L Jorgensen, et al.
Rheumatology (Oxford, England)|December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseasesSonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
Rheumatology Advances in Practice|January 23, 2025
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) studySaadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, et al.
Annals of the Rheumatic Diseases|February 26, 2015
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseasesMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, et al.
Pageof 18